The Cigna Group (NYSE:CI) Shares Acquired by Maj Invest Holding A S

Maj Invest Holding A S raised its holdings in The Cigna Group (NYSE:CI) by 1.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 503,921 shares of the health services provider’s stock after buying an additional 7,015 shares during the quarter. The Cigna Group accounts for approximately 4.6% of Maj Invest Holding A S’s holdings, making the stock its 10th biggest holding. Maj Invest Holding A S owned approximately 0.18% of The Cigna Group worth $139,153,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of CI. ORG Wealth Partners LLC bought a new position in shares of The Cigna Group during the 4th quarter worth approximately $34,000. Ulland Investment Advisors LLC lifted its holdings in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock valued at $36,000 after acquiring an additional 100 shares during the period. Prospera Private Wealth LLC bought a new position in shares of The Cigna Group during the third quarter valued at $37,000. Harbor Capital Advisors Inc. acquired a new stake in shares of The Cigna Group in the 3rd quarter valued at $45,000. Finally, Intact Investment Management Inc. bought a new stake in shares of The Cigna Group in the 3rd quarter worth about $69,000. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of CI stock opened at $294.18 on Monday. The firm’s 50 day moving average price is $297.18 and its two-hundred day moving average price is $325.59. The stock has a market cap of $81.82 billion, a PE ratio of 27.75, a PEG ratio of 0.78 and a beta of 0.54. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.72 and a current ratio of 0.72.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating the consensus estimate of $7.22 by $0.29. The firm had revenue of $63.70 billion for the quarter, compared to analyst estimates of $59.58 billion. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The company’s quarterly revenue was up 29.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.77 earnings per share. As a group, analysts forecast that The Cigna Group will post 28.5 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Royal Bank of Canada reduced their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Cantor Fitzgerald reissued an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. Deutsche Bank Aktiengesellschaft decreased their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research report on Monday, November 4th. Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up previously from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Finally, Barclays raised their target price on The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $395.93.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.